Shelby Bess

Graduate Research Assistant

Macrophage-targeted anti-CCL2 immunotherapy enhances tumor sensitivity to 5-fluorouracil in a Balb/c-CT26 murine colon carcinoma model measured using diffuse reflectance spectroscopy


Journal article


S. Bess, G. Greening, Narasimhan Rajaram, Timothy J. Muldoon
BMC Immunology, 2022

Semantic Scholar DOI
Cite

Cite

APA   Click to copy
Bess, S., Greening, G., Rajaram, N., & Muldoon, T. J. (2022). Macrophage-targeted anti-CCL2 immunotherapy enhances tumor sensitivity to 5-fluorouracil in a Balb/c-CT26 murine colon carcinoma model measured using diffuse reflectance spectroscopy. BMC Immunology.


Chicago/Turabian   Click to copy
Bess, S., G. Greening, Narasimhan Rajaram, and Timothy J. Muldoon. “Macrophage-Targeted Anti-CCL2 Immunotherapy Enhances Tumor Sensitivity to 5-Fluorouracil in a Balb/c-CT26 Murine Colon Carcinoma Model Measured Using Diffuse Reflectance Spectroscopy.” BMC Immunology (2022).


MLA   Click to copy
Bess, S., et al. “Macrophage-Targeted Anti-CCL2 Immunotherapy Enhances Tumor Sensitivity to 5-Fluorouracil in a Balb/c-CT26 Murine Colon Carcinoma Model Measured Using Diffuse Reflectance Spectroscopy.” BMC Immunology, 2022.


BibTeX   Click to copy

@article{s2022a,
  title = {Macrophage-targeted anti-CCL2 immunotherapy enhances tumor sensitivity to 5-fluorouracil in a Balb/c-CT26 murine colon carcinoma model measured using diffuse reflectance spectroscopy},
  year = {2022},
  journal = {BMC Immunology},
  author = {Bess, S. and Greening, G. and Rajaram, Narasimhan and Muldoon, Timothy J.}
}


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in